Pre-screener to be considered

Question Title

* 1. Address

Question Title

* 2. Confidentiality Consent: As a result of being selected to participate in this research, you may be exposed to proprietary or confidential information. This information may include, but is not limited to, experimental concepts, marketing, advertising, creative strategies and plans, product names or potential product names/marks and/or logos. By agreeing to participate in this research, you hereby agree: (a) to maintain the confidentiality of all the aforementioned information; (b) not to disclose such information to any person or entity without our prior written consent; (c) not to use such information without our prior written consent; (d) not to copy, print, or download any such information. Are you happy to participate with the interview on this basis?

Question Title

* 3. Adverse Event Reporting Consent: Different patients sometimes respond in different ways to the same medicine, and some side effects may not be discovered until many people have used a medicine over a period of time. For this reason, we are required to pass on to our client, who is a pharmaceutical company, details of any side effects/product complaints related to their own products that are mentioned during the course of market research. Although what you say will, of course, be treated in confidence, should you mention during the discussion a side effect when you, or someone you know, became ill after taking one of our client’s medicines, or a problem you have had with one of our clients medicines we will need to report this, so that they can learn more about the safety of their medicines. Are you happy to participate with the interview on this basis?

Question Title

* 4. What is your gender?

Question Title

* 5. What is your age?

Question Title

* 6. Which of the following conditions has a doctor diagnosed you with?

Question Title

* 7. Which condition were you diagnosed with first?

Question Title

* 8. Are you currently seeing a physician for the treatment of your Pulmonary Arterial Hypertension?

Question Title

* 9. Who would you consider primarily responsible for managing your PAH?

T